These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
462 related items for PubMed ID: 4853112
1. Measles susceptibility in two Pacific atoll populations. Epidemiological factors and response to live attenuated measles virus. Willis MF, Warburton MF. Med J Aust; 1974 May 18; 1(20):789-93. PubMed ID: 4853112 [No Abstract] [Full Text] [Related]
2. [Studies on the persistence of immunity 14-15 years after vaccination with a live measles vaccine]. Zhonghua Yi Xue Za Zhi; 1989 Jul 18; 69(7):389-91. PubMed ID: 2598095 [No Abstract] [Full Text] [Related]
3. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine. Isomura S, Morishima T, Nishikawa K, Hanada N, Rahman M, Terashima M, Kido S, Ueda S, Takahashi M. Biken J; 1986 Mar 18; 29(1):19-26. PubMed ID: 3778422 [Abstract] [Full Text] [Related]
4. [Measurement of the in vitro immune response of live attenuated measles virus vaccine and antibody levels in 0 to 10-year-old children]. Unalan H, Ustaçelebi S. Mikrobiyol Bul; 1985 Oct 18; 19(4):218-28. PubMed ID: 3831724 [Abstract] [Full Text] [Related]
5. The status of measles after five years of mass vaccination in the USSR. Burgasov PN, Andzaparidze OG, Popov VF. Bull World Health Organ; 1973 Oct 18; 49(6):571-6. PubMed ID: 4548384 [Abstract] [Full Text] [Related]
6. Booster vaccination with further live attenuated measles vaccine. Bass JW, Halstead SB, Fischer GW, Podgore JK, Pearl WR, Schydlower M, Wiebe RA, Ching FM. JAMA; 1976 Jan 05; 235(1):31-4. PubMed ID: 945997 [Abstract] [Full Text] [Related]
9. Persistence of vaccine-induced antibody to measles 26-33 years after vaccination. Dine MS, Hutchins SS, Thomas A, Williams I, Bellini WJ, Redd SC. J Infect Dis; 2004 May 01; 189 Suppl 1():S123-30. PubMed ID: 15106101 [Abstract] [Full Text] [Related]
10. An extremely attenuated, live measles virus vaccine (CAM-EX). Persistence of low titer-antibody in institutionalized children with psychomotor retardation after vaccination. Ueda K, Hashiguchi K, Nakashima F, Ueda S, Takahashi M. Biken J; 1981 Sep 01; 24(3):119-22. PubMed ID: 7337678 [Abstract] [Full Text] [Related]
11. The specific prevention of measles in Romania. Study of a vaccine prepared in human diploid cells. Cepleanu M, Cajal N, Cernescu C, Sorodoc Y, Aderca I, Tigăeru N, Suciu D, Manu S, Ferra A, Biberimoroianu S, Dobrescu A, Lucian M. Rev Roum Virol (1972); 1973 Sep 01; 10(1):8-17. PubMed ID: 4709858 [No Abstract] [Full Text] [Related]
14. Optimum age for measles immunisation: study of pre- and post-immunization level of HI antibody titres. Bhatnagar SK, Mohan M, Kumar P, Balaya S, Prabhakar AK, Bhargava SK. Indian Pediatr; 1981 Sep 01; 18(9):625-9. PubMed ID: 6797943 [No Abstract] [Full Text] [Related]
15. [Age-dependence of measles immunization failures]. Giesecke H, Brendel P, Schmidt J, Schlenk B. Z Gesamte Hyg; 1980 Sep 01; 26(10):764-67. PubMed ID: 7467503 [No Abstract] [Full Text] [Related]
16. [Optimal age for vaccination against measles]. José MV, Kumate J. Salud Publica Mex; 1989 Sep 01; 31(5):645-57. PubMed ID: 2692194 [Abstract] [Full Text] [Related]
20. Ineffectiveness of historical data in predicting measles susceptibility. Scott RM, Butler AB, Schydlower M, Rawlings P. Pediatrics; 1984 Jun 01; 73(6):777-80. PubMed ID: 6728580 [Abstract] [Full Text] [Related] Page: [Next] [New Search]